513 related articles for article (PubMed ID: 24138602)
1. Fixing frataxin: 'ironing out' the metabolic defect in Friedreich's ataxia.
Anzovino A; Lane DJ; Huang ML; Richardson DR
Br J Pharmacol; 2014 Apr; 171(8):2174-90. PubMed ID: 24138602
[TBL] [Abstract][Full Text] [Related]
2. Frataxin and the molecular mechanism of mitochondrial iron-loading in Friedreich's ataxia.
Chiang S; Kovacevic Z; Sahni S; Lane DJ; Merlot AM; Kalinowski DS; Huang ML; Richardson DR
Clin Sci (Lond); 2016 Jun; 130(11):853-70. PubMed ID: 27129098
[TBL] [Abstract][Full Text] [Related]
3. Drug repositioning screening identifies etravirine as a potential therapeutic for friedreich's ataxia.
Alfedi G; Luffarelli R; Condò I; Pedini G; Mannucci L; Massaro DS; Benini M; Toschi N; Alaimo G; Panarello L; Pacini L; Fortuni S; Serio D; Malisan F; Testi R; Rufini A
Mov Disord; 2019 Mar; 34(3):323-334. PubMed ID: 30624801
[TBL] [Abstract][Full Text] [Related]
4. Glutathione-dependent redox status of frataxin-deficient cells in a yeast model of Friedreich's ataxia.
Auchère F; Santos R; Planamente S; Lesuisse E; Camadro JM
Hum Mol Genet; 2008 Sep; 17(18):2790-802. PubMed ID: 18562474
[TBL] [Abstract][Full Text] [Related]
5. The role of frataxin in fission yeast iron metabolism: implications for Friedreich's ataxia.
Wang Y; Wang Y; Marcus S; Busenlehner LS
Biochim Biophys Acta; 2014 Oct; 1840(10):3022-33. PubMed ID: 24997422
[TBL] [Abstract][Full Text] [Related]
6. Adding a temporal dimension to the study of Friedreich's ataxia: the effect of frataxin overexpression in a human cell model.
Vannocci T; Notario Manzano R; Beccalli O; Bettegazzi B; Grohovaz F; Cinque G; de Riso A; Quaroni L; Codazzi F; Pastore A
Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29794127
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal Stem Cell-Derived Factors Restore Function to Human Frataxin-Deficient Cells.
Kemp K; Dey R; Cook A; Scolding N; Wilkins A
Cerebellum; 2017 Aug; 16(4):840-851. PubMed ID: 28456899
[TBL] [Abstract][Full Text] [Related]
8. Friedreich's ataxia.
Alper G; Narayanan V
Pediatr Neurol; 2003 May; 28(5):335-41. PubMed ID: 12878293
[TBL] [Abstract][Full Text] [Related]
9. Elucidation of the mechanism of mitochondrial iron loading in Friedreich's ataxia by analysis of a mouse mutant.
Huang ML; Becker EM; Whitnall M; Suryo Rahmanto Y; Ponka P; Richardson DR
Proc Natl Acad Sci U S A; 2009 Sep; 106(38):16381-6. PubMed ID: 19805308
[TBL] [Abstract][Full Text] [Related]
10. Friedreich's ataxia: the vicious circle hypothesis revisited.
Bayot A; Santos R; Camadro JM; Rustin P
BMC Med; 2011 Oct; 9():112. PubMed ID: 21985033
[TBL] [Abstract][Full Text] [Related]
11. Friedreich's ataxia: clinical features, pathogenesis and management.
Cook A; Giunti P
Br Med Bull; 2017 Dec; 124(1):19-30. PubMed ID: 29053830
[TBL] [Abstract][Full Text] [Related]
12. Understanding the molecular mechanisms of Friedreich's ataxia to develop therapeutic approaches.
Schmucker S; Puccio H
Hum Mol Genet; 2010 Apr; 19(R1):R103-10. PubMed ID: 20413654
[TBL] [Abstract][Full Text] [Related]
13. Frataxin: its role in iron metabolism and the pathogenesis of Friedreich's ataxia.
Becker E; Richardson DR
Int J Biochem Cell Biol; 2001 Jan; 33(1):1-10. PubMed ID: 11167127
[TBL] [Abstract][Full Text] [Related]
14. Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.
Gomes CM; Santos R
Oxid Med Cell Longev; 2013; 2013():487534. PubMed ID: 23936609
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis as a Novel Therapeutic Target for Friedreich's Ataxia.
Cotticelli MG; Xia S; Lin D; Lee T; Terrab L; Wipf P; Huryn DM; Wilson RB
J Pharmacol Exp Ther; 2019 Apr; 369(1):47-54. PubMed ID: 30635474
[TBL] [Abstract][Full Text] [Related]
16. Lipophilic methylene blue analogues enhance mitochondrial function and increase frataxin levels in a cellular model of Friedreich's ataxia.
Khdour OM; Bandyopadhyay I; Chowdhury SR; Visavadiya NP; Hecht SM
Bioorg Med Chem; 2018 Jul; 26(12):3359-3369. PubMed ID: 29773347
[TBL] [Abstract][Full Text] [Related]
17. Towards a structural understanding of Friedreich's ataxia: the solution structure of frataxin.
Musco G; Stier G; Kolmerer B; Adinolfi S; Martin S; Frenkiel T; Gibson T; Pastore A
Structure; 2000 Jul; 8(7):695-707. PubMed ID: 10903947
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial dysfunction in the neuro-degenerative and cardio-degenerative disease, Friedreich's ataxia.
Chiang S; Kalinowski DS; Jansson PJ; Richardson DR; Huang ML
Neurochem Int; 2018 Jul; 117():35-48. PubMed ID: 28782591
[TBL] [Abstract][Full Text] [Related]
19. Friedreich's Ataxia: disease mechanisms, antioxidant and Coenzyme Q10 therapy.
Cooper JM; Schapira AH
Biofactors; 2003; 18(1-4):163-71. PubMed ID: 14695932
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Prospects for Friedreich's Ataxia.
Zhang S; Napierala M; Napierala JS
Trends Pharmacol Sci; 2019 Apr; 40(4):229-233. PubMed ID: 30905359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
